Cord Direct Antiglobulin Test for Predicting the Need for Phototherapy in Neonates with ABO Incompatibility: A Prospective Cohort Study

Introduction: The Direct Antiglobulin Test (DAT) is a screening technique used to detect Immunoglobulin G (IgG) antierythrocyte antibodies on foetal Red Blood Cells (RBCs). Universal bilirubin screening decreases the incidence of severe hyperbilirubinemia. The diagnostic efficacy of DAT in cases of...

Full description

Saved in:
Bibliographic Details
Main Authors: Ranjith Balan, Sakthipriya Balaji, Arun Kumar, Subash Sundar, Shrinidhi Krishnan, Ashok Chandrasekaran
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2025-02-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/20587/74398_CE[Ra1]_F(SL)_QC(PS_SS)_PF1(AG_SS)_PFA(IS)_PB(AG_IS)_PN(IS).pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823858329054609408
author Ranjith Balan
Sakthipriya Balaji
Arun Kumar
Subash Sundar
Shrinidhi Krishnan
Ashok Chandrasekaran
author_facet Ranjith Balan
Sakthipriya Balaji
Arun Kumar
Subash Sundar
Shrinidhi Krishnan
Ashok Chandrasekaran
author_sort Ranjith Balan
collection DOAJ
description Introduction: The Direct Antiglobulin Test (DAT) is a screening technique used to detect Immunoglobulin G (IgG) antierythrocyte antibodies on foetal Red Blood Cells (RBCs). Universal bilirubin screening decreases the incidence of severe hyperbilirubinemia. The diagnostic efficacy of DAT in cases of ABO incompatibility is not well established, in contrast to Rh incompatibility. Aim: To evaluate the diagnostic ability of routine cord blood DAT in neonates ≥35 weeks of gestation with ABO incompatibility in predicting the requirement for phototherapy. Additionally, to compare the diagnostic ability between two methods of DAT estimation, namely the semiagglutination gel method and the conventional tube method. Materials and Methods: This prospective cohort study was conducted from September 2022 to March 2024 at SRM Medical College Hospital and Research Centre, Chennai, Tamil Nadu, India. Following the acquisition of informed consent, cord blood samples were collected from 934 neonates delivered after 35 weeks of completed gestation to mothers with O blood type. In cases of ABO incompatibility (523 neonates), DAT was performed using both the manual tube method and the automated semiagglutination gel method in the blood bank. Serum bilirubin levels, complete blood counts with peripheral smear analysis and reticulocyte counts were performed on day 3 or earlier, as clinically indicated. The neonates were treated in accordance with the American Academy of Paediatrics (AAP) 2004 recommendations on phototherapy. Babies were monitored for jaundice until 14 days of age. Results: Out of 3,092 eligible deliveries, 523 babies with ABO incompatibility were enrolled. The baseline characteristics were comparable. Bilirubin levels in DAT-positive and DAT-negative neonates were 14.60±3.58 mg% and 13.18±3.16 mg% (p-value <0.001), respectively. The adjusted odds ratio of positive DAT for both methods in predicting the requirement for phototherapy was 3.21 (95% CI 2.1-5.8). The sensitivity, specificity, positive likelihood ratio and negative likelihood ratio of the tube method were 37.5%, 85.16%, 2.53, and 0.73, respectively, while for the gel method they were 37.08%, 86.57%, 2.76, and 0.73, respectively. Conclusion: In cases of ABO incompatibility, neonates with positive cord DAT had higher odds of requiring phototherapy; however, a high negative likelihood ratio indicates that additional factors may be involved in hyperbilirubinemia that necessitate phototherapy.
format Article
id doaj-art-3b0feee80db94e079e1301e1522346ea
institution Kabale University
issn 2249-782X
0973-709X
language English
publishDate 2025-02-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj-art-3b0feee80db94e079e1301e1522346ea2025-02-11T12:04:39ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2025-02-011902010510.7860/JCDR/2025/74398.20587Cord Direct Antiglobulin Test for Predicting the Need for Phototherapy in Neonates with ABO Incompatibility: A Prospective Cohort StudyRanjith Balan0Sakthipriya Balaji1Arun Kumar2Subash Sundar3Shrinidhi Krishnan4Ashok Chandrasekaran5Postgraduate Student, Department of Paediatrics, SRM Medical College Hospital and Research Centre, SRMIST, Chennai, Tamil Nadu, India.Assistant Professor, Department of Transfusion Medicine, SRM Medical College Hospital and Research Centre, SRMIST, Chennai, Tamil Nadu, India.Assistant Professor, Department of Paediatrics, SRM Medical College Hospital and Research Centre, SRMIST, Chennai, Tamil Nadu, India.Professor and Head, Department of Paediatrics, SRM Medical College Hospital and Research Centre, SRMIST, Chennai, Tamil Nadu, India.Assistant Professor, Department of Paediatrics, SRM Medical College Hospital and Research Centre, SRMIST, Chennai, Tamil Nadu, India.Associate Professor, Department of Neonatology, SRM Medical College Hospital and Research Centre, SRMIST, Chennai, Tamil Nadu, India.Introduction: The Direct Antiglobulin Test (DAT) is a screening technique used to detect Immunoglobulin G (IgG) antierythrocyte antibodies on foetal Red Blood Cells (RBCs). Universal bilirubin screening decreases the incidence of severe hyperbilirubinemia. The diagnostic efficacy of DAT in cases of ABO incompatibility is not well established, in contrast to Rh incompatibility. Aim: To evaluate the diagnostic ability of routine cord blood DAT in neonates ≥35 weeks of gestation with ABO incompatibility in predicting the requirement for phototherapy. Additionally, to compare the diagnostic ability between two methods of DAT estimation, namely the semiagglutination gel method and the conventional tube method. Materials and Methods: This prospective cohort study was conducted from September 2022 to March 2024 at SRM Medical College Hospital and Research Centre, Chennai, Tamil Nadu, India. Following the acquisition of informed consent, cord blood samples were collected from 934 neonates delivered after 35 weeks of completed gestation to mothers with O blood type. In cases of ABO incompatibility (523 neonates), DAT was performed using both the manual tube method and the automated semiagglutination gel method in the blood bank. Serum bilirubin levels, complete blood counts with peripheral smear analysis and reticulocyte counts were performed on day 3 or earlier, as clinically indicated. The neonates were treated in accordance with the American Academy of Paediatrics (AAP) 2004 recommendations on phototherapy. Babies were monitored for jaundice until 14 days of age. Results: Out of 3,092 eligible deliveries, 523 babies with ABO incompatibility were enrolled. The baseline characteristics were comparable. Bilirubin levels in DAT-positive and DAT-negative neonates were 14.60±3.58 mg% and 13.18±3.16 mg% (p-value <0.001), respectively. The adjusted odds ratio of positive DAT for both methods in predicting the requirement for phototherapy was 3.21 (95% CI 2.1-5.8). The sensitivity, specificity, positive likelihood ratio and negative likelihood ratio of the tube method were 37.5%, 85.16%, 2.53, and 0.73, respectively, while for the gel method they were 37.08%, 86.57%, 2.76, and 0.73, respectively. Conclusion: In cases of ABO incompatibility, neonates with positive cord DAT had higher odds of requiring phototherapy; however, a high negative likelihood ratio indicates that additional factors may be involved in hyperbilirubinemia that necessitate phototherapy.https://jcdr.net/articles/PDF/20587/74398_CE[Ra1]_F(SL)_QC(PS_SS)_PF1(AG_SS)_PFA(IS)_PB(AG_IS)_PN(IS).pdfblood group incompatibilitycoomb’s testneonatal hyperbilirubinemiapredictive value
spellingShingle Ranjith Balan
Sakthipriya Balaji
Arun Kumar
Subash Sundar
Shrinidhi Krishnan
Ashok Chandrasekaran
Cord Direct Antiglobulin Test for Predicting the Need for Phototherapy in Neonates with ABO Incompatibility: A Prospective Cohort Study
Journal of Clinical and Diagnostic Research
blood group incompatibility
coomb’s test
neonatal hyperbilirubinemia
predictive value
title Cord Direct Antiglobulin Test for Predicting the Need for Phototherapy in Neonates with ABO Incompatibility: A Prospective Cohort Study
title_full Cord Direct Antiglobulin Test for Predicting the Need for Phototherapy in Neonates with ABO Incompatibility: A Prospective Cohort Study
title_fullStr Cord Direct Antiglobulin Test for Predicting the Need for Phototherapy in Neonates with ABO Incompatibility: A Prospective Cohort Study
title_full_unstemmed Cord Direct Antiglobulin Test for Predicting the Need for Phototherapy in Neonates with ABO Incompatibility: A Prospective Cohort Study
title_short Cord Direct Antiglobulin Test for Predicting the Need for Phototherapy in Neonates with ABO Incompatibility: A Prospective Cohort Study
title_sort cord direct antiglobulin test for predicting the need for phototherapy in neonates with abo incompatibility a prospective cohort study
topic blood group incompatibility
coomb’s test
neonatal hyperbilirubinemia
predictive value
url https://jcdr.net/articles/PDF/20587/74398_CE[Ra1]_F(SL)_QC(PS_SS)_PF1(AG_SS)_PFA(IS)_PB(AG_IS)_PN(IS).pdf
work_keys_str_mv AT ranjithbalan corddirectantiglobulintestforpredictingtheneedforphototherapyinneonateswithaboincompatibilityaprospectivecohortstudy
AT sakthipriyabalaji corddirectantiglobulintestforpredictingtheneedforphototherapyinneonateswithaboincompatibilityaprospectivecohortstudy
AT arunkumar corddirectantiglobulintestforpredictingtheneedforphototherapyinneonateswithaboincompatibilityaprospectivecohortstudy
AT subashsundar corddirectantiglobulintestforpredictingtheneedforphototherapyinneonateswithaboincompatibilityaprospectivecohortstudy
AT shrinidhikrishnan corddirectantiglobulintestforpredictingtheneedforphototherapyinneonateswithaboincompatibilityaprospectivecohortstudy
AT ashokchandrasekaran corddirectantiglobulintestforpredictingtheneedforphototherapyinneonateswithaboincompatibilityaprospectivecohortstudy